{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"100"},{"groupId":"OG005","value":"52"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"213"},{"groupId":"OG005","value":"85"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"2"}],"units":"Participants"}],"description":"Disease-Free Survival is the length of time during and after medication or treatment during which the disease being treated (usually cancer) does not get worse. It is sometimes used as a metric to study the health of a person with a disease to try to determine how well a new treatment is working.","groups":[{"description":"Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Peripheral Blood Stem Cells (PBSC) as a source of transplant","id":"OG000","title":"PBSC: No TBI"},{"description":"Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Bone Marrow as a source of stem cell transplant","id":"OG001","title":"Marrow : No TBI"},{"description":"Patients who are not able to receive Total Body Irradiation (TBI) receives cyclophosphamide, Busulfan and Umbilical Cord Blood (UCB) as a source of stem cell transplant","id":"OG002","title":"UCB : No TBI"},{"description":"Patients who receives Umbilical Cord Blood (UCB) as a source of transplant and who have not had chemotherapy in the prior 3 months receives ATG in addition to cyclophosphamide, Busulfan preparative regimen","id":"OG003","title":"UCB : No TBI/Bu/Cy/ATG"},{"description":"Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Peripheral blood stem cells as a source of transplant","id":"OG004","title":"PBSC"},{"description":"Patients receiving cyclophosphamide, Total Body Irradiation (TBI) and Bone Marrow as a source of stem cell transplant","id":"OG005","title":"Marrow"},{"description":"Patients receiving cyclophosphamide, Total Body Irradiation (TBI), and Umbilical Cord Blood (UCB) as a source of stem cell transplant","id":"OG006","title":"Umbilical Cord Blood"},{"description":"Patients receiving cyclophosphamide, Total Body Irradiation (TBI) , CD4+CD25+ and Peripheral Blood Stem Cells (PBSC) as a source of transplant. These patients are co-enrolled on the MT2004-03 trial (NCT00725062)","id":"OG007","title":"Co-Enroll From MT0403"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"2 years","title":"Number of Participants Experiencing Disease-Free Survival at 2 Years Post Transplant","type":"PRIMARY","unitOfMeasure":"Participants"}